Research experience
-
Jan 2008–
Dec 2012Research: Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey · Department of Pharmacology and ToxicologyUSA · New Brunswick -
Jan 2000–
Dec 2008Research: The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia · Department of PediatricsUSA · Philadelphia -
Jan 1998–
Dec 2002Research: Howard Hughes Medical Institute
Howard Hughes Medical InstituteUSA · Chevy Chase -
Jan 1998–
Dec 2009Research: Duke University
Duke University · Department of MedicineUSA · Durham -
Jan 1997–
Dec 2010Research: Hospital of the University of Pennsylvania
Hospital of the University of PennsylvaniaUSA · Philadelphia -
Jan 1996–
Dec 2009Research: University of Pennsylvania
University of Pennsylvania · Institute for Environmental MedicineUSA · Philadelphia
Other
-
Scientific MembershipsNitric Oxide Society
AAAS
Publications (97) View all
-
Article: Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.
[show abstract] [hide abstract]
ABSTRACT: Inhaled nitric oxide (iNO) is a potential new therapy for prevention of bronchopulmonary dysplasia and brain injury in premature infants. This study examined dose-related effects of iNO on NO metabolites as evidence of NO delivery. A subset of 102 premature infants in the NO CLD trial, receiving 24 days of iNO (20 p.p.m. decreasing to 2 p.p.m.) or placebo, were analyzed. Tracheal aspirate (TA) and plasma samples collected at enrollment and at intervals during study gas were analyzed for NO metabolites. iNO treatment increased NO metabolites in TA at 20 and 10 p.p.m. (1.7- to 2.3-fold vs control) and in plasma at 20, 10, and 5 p.p.m. (1.6- to 2.3-fold). In post hoc analysis, treated infants with lower metabolite levels at entry had an improved clinical outcome. iNO causes dose-related increases in NO metabolites in the circulation as well as lung fluid, as evidenced by TA analysis, showing NO delivery to these compartments.Journal of perinatology: official journal of the California Perinatal Association 10/2009; 30(4):275-80. · 1.59 Impact Factor -
SourceAvailable from: Elena N Atochina-Vasserman
Article: SP-D-dependent regulation of NO metabolism in lipopolysaccharide-stimulated peritoneal macrophages.
E N Atochina-Vasserman, E V Abramova, Y Tomer, P Scott, V A Nazarov, S V Kruglov, M F Beers, A J Gow, I Yu Malyshev[show abstract] [hide abstract]
ABSTRACT: This work was designed to study the role of surfactant protein D in the regulation of NO synthesis by "non-alveolar" microphages. We evaluated whether the effects of surfactant protein D depend on the phenotype of macrophages. In the absence of surfactant protein D, the LPS-induced iNOS response was shown to decrease in macrophages of native and proinflammatory phenotypes by 30%, and in macrophages of the antiinflammatory phenotype (by 63%). Under the influence of lipopolysaccharide in high doses (500 ng/ml), NO(2)*- production by mouse macrophages without surfactant protein D was reduced in native cells (by 25%), but increased in proinflammatory (by 40%) and antiinflammatory phenotypes (by 12% compared to mouse macrophages with surfactant protein D). Our results suggest that surfactant protein D is involved in the immune response in the whole organism, but not only in the lungs. The effect of surfactant protein D depends on the phenotype of macrophages.Bulletin of Experimental Biology and Medicine 05/2009; 147(4):415-20. · 0.27 Impact Factor -
Article: A cis-proline in alpha-hemoglobin stabilizing protein directs the structural reorganization of alpha-hemoglobin.
David A Gell, Liang Feng, Suiping Zhou, Philip D Jeffrey, Katerina Bendak, Andrew Gow, Mitchell J Weiss, Yigong Shi, Joel P Mackay[show abstract] [hide abstract]
ABSTRACT: alpha-Hemoglobin (alphaHb) stabilizing protein (AHSP) is expressed in erythropoietic tissues as an accessory factor in hemoglobin synthesis. AHSP forms a specific complex with alphaHb and suppresses the heme-catalyzed evolution of reactive oxygen species by converting alphaHb to a conformation in which the heme is coordinated at both axial positions by histidine side chains (bis-histidyl coordination). Currently, the detailed mechanism by which AHSP induces structural changes in alphaHb has not been determined. Here, we present x-ray crystallography, NMR spectroscopy, and mutagenesis data that identify, for the first time, the importance of an evolutionarily conserved proline, Pro(30), in loop 1 of AHSP. Mutation of Pro(30) to a variety of residue types results in reduced ability to convert alphaHb. In complex with alphaHb, AHSP Pro(30) adopts a cis-peptidyl conformation and makes contact with the N terminus of helix G in alphaHb. Mutations that stabilize the cis-peptidyl conformation of free AHSP, also enhance the alphaHb conversion activity. These findings suggest that AHSP loop 1 can transmit structural changes to the heme pocket of alphaHb, and, more generally, highlight the importance of cis-peptidyl prolyl residues in defining the conformation of regulatory protein loops.Journal of Biological Chemistry 09/2009; 284(43):29462-9. · 4.77 Impact Factor -
Article: Tocopherol Supplementation Reduces NO Production and Pulmonary Inflammatory Response to Bleomycin.
Jin Dong Shi, Thea Golden, Chang-Jiang Guo, Shui Ping Tu, Pamela Scott, Mao-Jung Lee, Chung S Yang, Andrew J Gow[show abstract] [hide abstract]
ABSTRACT: Bleomycin causes acute lung injury through production of reactive species and initiation of inflammation. Previous work has shown alteration to the production of reactive oxygen species results in attenuation of injury. Vitamin E, in particular, γ-tocopherol, isoform, has the potential to scavenge reactive oxygen and nitrogen species. This study examines the utility of dietary supplementation with tocopherols in reducing bleomycin-mediated acute lung injury. Male C57BL6/J mice were intratracheally instilled with PBS or 2 units/kg bleomycin. Animals were analyzed 3 and 8 days post instillation at the cellular, tissue, and organ levels. Results showed successful delivery of tocopherols to the lung via dietary supplementation. Also, increases in reactive oxygen and nitrogen species due to bleomycin are normalized in those mice fed tocopherol diet. Injury was not prevented but inflammation progression was altered, in particular macrophage activation and function. Inflammatory scores based on histology demonstrate limited progression of inflammation in those mice treated with bleomycin and fed tocopherol diet compared to control diet. Upregulation of enzymes and cytokines involved in pro-inflammation were limited by tocopherol supplementation. Day 3 functional changes in elastance in response to bleomycin are prevented, however, 8 days post injury the effect of the tocopherol diet is lost. The effect of tocopherol supplementation upon the inflammatory process is demonstrated by a shift in the phenotype of macrophage activation. The effect of these changes on resolution and the progression of pulmonary fibrosis has yet to be elucidated.Nitric Oxide 05/2013; · 3.55 Impact Factor -
SourceAvailable from: Elena N Atochina-Vasserman
Dataset: 2011 Segmental Allergen challenge -online data supplement
Michael F Beers, Helen Abramova, Carla Winkler, Frank Schaumann, Jens M Hohlfeld, Norbert Krug, Elena N Atochina-Vasserman, Andrew J Gow